COPART vs PTCT
COPART (COPART) versus PTC Therapeutics Inc (PTCT) — a side-by-side from cached financials, not a winner call.
COPART (COPART) common stock.
PTC Therapeutics Inc (PTCT) is a biotechnology company listed on NASDAQ.
COPART does not have a complete income-statement cache yet.
Latest reported PTCT revenue for 2026-06-30 was $633.1M. Net income was $80.7M. PTCT currently screens at market cap $6.51B.
PTCT currently screens at market cap $6.51B.
Not investment advice. Open the COPART and PTCT stock pages for the full models.
Not investment advice.